abstract |
The present invention relates to N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-methylindolyl-6-((4-methyl-2-) Granules of oxypiperidin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridin-1(2H)-formamide; method of preparing the granules; comprising the granules Pharmaceutical compositions; and methods of using the pharmaceutical compositions to treat cancer. |